van Zyl: N-myristoyltransferase inhibitors for the treatment and elimination of dormant forms of Plasmodium vivax malaria phase 1 indirect costs award
van Zyl: N-myristoyltransferase inhibitors for the treatment and elimination of dormant forms of Plasmodium vivax malaria phase 1 indirect costs award